These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22050742)

  • 1. 1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 1): action in ion channels and GPCRs.
    Ioan P; Carosati E; Micucci M; Cruciani G; Broccatelli F; Zhorov BS; Chiarini A; Budriesi R
    Curr Med Chem; 2011; 18(32):4901-22. PubMed ID: 22050742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 1,4-dihydropyridine nucleus: a pharmacophoric template part 1. Actions at ion channels.
    Triggle DJ
    Mini Rev Med Chem; 2003 May; 3(3):215-23. PubMed ID: 12570837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 2): action in other targets and antitargets.
    Carosati E; Ioan P; Micucci M; Broccatelli F; Cruciani G; Zhorov BS; Chiarini A; Budriesi R
    Curr Med Chem; 2012; 19(25):4306-23. PubMed ID: 22709009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity.
    Bladen C; Gündüz MG; Şimşek R; Şafak C; Zamponi GW
    Pflugers Arch; 2014 Jul; 466(7):1355-63. PubMed ID: 24149495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers.
    Teleb M; Zhang FX; Farghaly AM; Aboul Wafa OM; Fronczek FR; Zamponi GW; Fahmy H
    Eur J Med Chem; 2017 Jul; 134():52-61. PubMed ID: 28399450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.
    Schaller D; Gündüz MG; Zhang FX; Zamponi GW; Wolber G
    Eur J Med Chem; 2018 Jul; 155():1-12. PubMed ID: 29843108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic screen for dihydropyridine (DHP)-resistant worms reveals new residues required for DHP-blockage of mammalian calcium channels.
    Kwok TC; Hui K; Kostelecki W; Ricker N; Selman G; Feng ZP; Roy PJ
    PLoS Genet; 2008 May; 4(5):e1000067. PubMed ID: 18464914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,4-Dihydropyridines as calcium channel ligands and privileged structures.
    Triggle DJ
    Cell Mol Neurobiol; 2003 Jun; 23(3):293-303. PubMed ID: 12825828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the inhibitory effect of dihydropyridines on N-type calcium channel by virtual three-dimensional pharmacophore modeling.
    Ogihara T; Kano T; Kakinuma C
    Arzneimittelforschung; 2009; 59(6):283-8. PubMed ID: 19634509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of L-type Ca2+ channels CaV1.3 and CaV1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics.
    Kang S; Cooper G; Dunne SF; Luan CH; James Surmeier D; Silverman RB
    Bioorg Med Chem; 2013 Jul; 21(14):4365-73. PubMed ID: 23688558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fused 1,4-dihydropyridines as potential calcium modulatory compounds.
    Safak C; Simsek R
    Mini Rev Med Chem; 2006 Jul; 6(7):747-55. PubMed ID: 16842124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural model for dihydropyridine binding to L-type calcium channels.
    Tikhonov DB; Zhorov BS
    J Biol Chem; 2009 Jul; 284(28):19006-17. PubMed ID: 19416978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction of 1,4-dihydropyridines with ion channels].
    Veizerová L; Svetlík J; Kettmann V
    Ceska Slov Farm; 2008 Apr; 57(2):58-62. PubMed ID: 18578414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereochemical requirements for the mineralocorticoid receptor antagonist activity of dihydropyridines.
    Arhancet GB; Woodard SS; Dietz JD; Garland DJ; Wagner GM; Iyanar K; Collins JT; Blinn JR; Numann RE; Hu X; Huang HC
    J Med Chem; 2010 May; 53(10):4300-4. PubMed ID: 20408553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship of dihydropyridines for rhabdomyosarcoma.
    Chauhan S; Woods AD; Bharathy N; Lian X; Ricker CA; Mantz A; Zuercher WJ; Price LH; Morton MJ; Durrant E; Corbel SY; Sampath SC; Sampath SC; Joslin J; Keller C
    Biochem Biophys Res Commun; 2023 Jul; 667():138-145. PubMed ID: 37224633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel dihydropyridine with 3-aryl meta-hydroxyl substitution blocks L-type calcium channels in rat cardiomyocytes.
    Galvis-Pareja D; Zapata-Torres G; Hidalgo J; Ayala P; Pedrozo Z; Ibarra C; Diaz-Araya G; Hall AR; Vicencio JM; Nuñez-Vergara L; Lavandero S
    Toxicol Appl Pharmacol; 2014 Aug; 279(1):53-62. PubMed ID: 24844443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric interactions required for high-affinity binding of dihydropyridine antagonists to Ca(V)1.1 Channels are modulated by calcium in the pore.
    Peterson BZ; Catterall WA
    Mol Pharmacol; 2006 Aug; 70(2):667-75. PubMed ID: 16675661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,4-Dihydropyridine: A Dependable Heterocyclic Ring with the Promising and the Most Anticipable Therapeutic Effects.
    Mishra AP; Bajpai A; Rai AK
    Mini Rev Med Chem; 2019; 19(15):1219-1254. PubMed ID: 31735158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focusing on C-4 position of Hantzsch 1,4-dihydropyridines: Molecular modifications, enantioseparation, and binding mechanism to L- and T-type calcium channels.
    Akman D; Denzinger K; Huang S; Lee JT; Nafie JW; Wolber G; Zamponi GW; Armstrong DW; Gündüz MG
    Eur J Med Chem; 2022 Dec; 244():114787. PubMed ID: 36209630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivities of CaV1.2 IIS5-S6 mutants to 1,4-dihydropyridine analogs.
    Hui K; Kwok TC; Kostelecki W; Leen J; Roy PJ; Feng ZP
    Eur J Pharmacol; 2009 Jan; 602(2-3):255-61. PubMed ID: 19068212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.